Investor Relations

Stock price graph

GenMark Dx's mission is to become the market leader in providing high value, simple to perform, clinically relevant multiplex molecular tests to aid in the diagnosis of disease and the selection and dosing of therapies.

For investor information, please contact IR@genmarkdx.com.

Annual Reports

2014 Proxy Statement

2013 Annual Report

2013 Proxy Statement

2012 Annual Report

2011 Annual Report

2012 Proxy Statement


Recent Releases

Nov 5, 2014
GenMark Diagnostics to Present at the Canaccord Genuity Medical Technology and Diagnostics Forum

Oct 30, 2014
GenMark Diagnostics Reports Third Quarter 2014 Results

View all releases »

Related Links

Stock Quote
Price:
13.57
Change:
+ 0.18
Day High:
13.71
Day Low:
13.15
Volume:
327,500
NASDAQ
GNMK
4:00 PM ET on Dec 19, 2014
Delayed at least 20 minutes.
Provided by eSignal.